Cite

HARVARD Citation

    Llovet, J. et al. (2002). Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 50 (1), pp. 123-128. [Online]. 
  
Back to record